These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26651519)

  • 1. Antibodies to watch in 2016.
    Reichert JM
    MAbs; 2016; 8(2):197-204. PubMed ID: 26651519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to watch in 2015.
    Reichert JM
    MAbs; 2015; 7(1):1-8. PubMed ID: 25484055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to watch in 2017.
    Reichert JM
    MAbs; 2017; 9(2):167-181. PubMed ID: 27960628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to watch in 2018.
    Kaplon H; Reichert JM
    MAbs; 2018; 10(2):183-203. PubMed ID: 29300693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to watch in 2014.
    Reichert JM
    MAbs; 2014 Jan; 6(1):5-14. PubMed ID: 24284914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which are the antibodies to watch in 2013?
    Reichert JM
    MAbs; 2013; 5(1):1-4. PubMed ID: 23254906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to watch in 2020.
    Kaplon H; Muralidharan M; Schneider Z; Reichert JM
    MAbs; 2020; 12(1):1703531. PubMed ID: 31847708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to watch in 2014: mid-year update.
    Reichert JM
    MAbs; 2014; 6(4):799-802. PubMed ID: 24846335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to watch in 2019.
    Kaplon H; Reichert JM
    MAbs; 2019; 11(2):219-238. PubMed ID: 30516432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to watch in 2013: Mid-year update.
    Reichert JM
    MAbs; 2013; 5(4):513-7. PubMed ID: 23727858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to watch in 2023.
    Kaplon H; Crescioli S; Chenoweth A; Visweswaraiah J; Reichert JM
    MAbs; 2023; 15(1):2153410. PubMed ID: 36472472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to watch in 2021.
    Kaplon H; Reichert JM
    MAbs; 2021; 13(1):1860476. PubMed ID: 33459118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to watch in 2022.
    Kaplon H; Chenoweth A; Crescioli S; Reichert JM
    MAbs; 2022; 14(1):2014296. PubMed ID: 35030985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-based therapeutics to watch in 2011.
    Reichert JM
    MAbs; 2011; 3(1):76-99. PubMed ID: 21051951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer antibodies.
    Ross JS; Gray K; Gray GS; Worland PJ; Rolfe M
    Am J Clin Pathol; 2003 Apr; 119(4):472-85. PubMed ID: 12710120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to watch in 2024.
    Crescioli S; Kaplon H; Chenoweth A; Wang L; Visweswaraiah J; Reichert JM
    MAbs; 2024; 16(1):2297450. PubMed ID: 38178784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in the clinical development of asthma therapies.
    Staton TL; Choy DF; Arron JR
    Biomark Med; 2016; 10(2):165-76. PubMed ID: 26764286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-based therapeutics in oncology.
    Ross J; Gray K; Schenkein D; Greene B; Gray GS; Shulok J; Worland PJ; Celniker A; Rolfe M
    Expert Rev Anticancer Ther; 2003 Feb; 3(1):107-21. PubMed ID: 12597355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European drug market entries 2015 with new mechanisms of action.
    van den Heuvel TW; Cohen AF; Rissmann R
    Clin Med (Lond); 2016 Oct; 16(5):475-480. PubMed ID: 27697814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody: the corner stone of modern biotherapeutics.
    Xia ZN; Cai XT; Cao P
    Yao Xue Xue Bao; 2012 Oct; 47(10):1275-80. PubMed ID: 23289138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.